Dyadic International DSO Ratio 2011-2026 | DYAI

Annual DSO Ratio Dyadic International

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
78.4	36.7	50.1	37.9	43.4	92.6	247	316	366	666	91.3	30.5	38.1	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
666	30.5	161

Quarterly DSO Ratio Dyadic International

2025-Q3	2025-Q2	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
63.9	45	-	14.1	58.6	97.1	-	136	82.9	50.6	-	71.6	36.7 K	37.2 K	-	31	32.9	0.07	-	64.5	51.2	123	-	112	130	99.4	-	111	180	146	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
37.2 K	0.07	3.28 K

DSO Ratio of other stocks in the Biotechnology industry

Issuer	DSO Ratio	Price	% 24h	Market Cap	Country
AbbVie ABBV	258	$ 209.63	-0.71 %	$ 371 B	USA
Verastem VSTM	38.5	$ 4.99	-5.77 %	$ 346 M	USA
VistaGen Therapeutics VTGN	28.9	$ 0.57	-5.85 %	$ 17.6 M	USA
Aeterna Zentaris AEZS	146	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	186	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	216	-	-	$ 1.01 B	USA
AIkido Pharma AIKI	17.9	-	1.93 %	$ 17.4 M	USA
I-Mab IMAB	271	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	84.7	-	-	$ 40.3 B	USA
Albireo Pharma ALBO	14.7	-	-0.23 %	$ 916 M	USA
Voyager Therapeutics VYGR	14.8	$ 3.96	-4.24 %	$ 232 M	USA
Aptinyx APTX	46.9	-	-39.0 %	$ 4.57 M	USA
Midatech Pharma plc MTP	204	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	2.75 K	-	-1.52 %	$ 24.7 M	USA
Arena Pharmaceuticals ARNA	946	-	-6.81 %	$ 3.04 B	USA
Applied Genetic Technologies Corporation AGTC	0.114	-	-	$ 26.5 M	USA
Ayala Pharmaceuticals AYLA	61.7	-	-	$ 7.46 M	Israel
Acorda Therapeutics ACOR	48.3	-	-24.86 %	$ 820 K	USA
bluebird bio BLUE	2.47	-	-	$ 546 M	USA
Acasti Pharma ACST	1.97	-	4.01 %	$ 150 M	Canada
Avid Bioservices CDMO	45.6	-	-	$ 789 M	USA
Adverum Biotechnologies ADVM	222	-	-	$ 86.2 M	USA
Advaxis ADXS	88.1	-	-9.65 %	$ 45.9 M	USA
Adaptive Biotechnologies Corporation ADPT	60.7	$ 12.36	-11.46 %	$ 1.88 B	USA
Wave Life Sciences Ltd. WVE	11.5	$ 6.39	3.06 %	$ 1.08 B	Singapore
Xenetic Biosciences XBIO	365	$ 2.78	-0.71 %	$ 4.73 M	USA
BeiGene, Ltd. BGNE	52.6	-	0.49 %	$ 251 B	Cayman-islands
XBiotech XBIT	40.8	$ 2.27	-1.73 %	$ 69.2 M	USA
Xenon Pharmaceuticals XENE	72.6	$ 54.44	-1.96 %	$ 4.24 B	Canada
Xeris Pharmaceuticals XERS	57.2	$ 5.41	-2.87 %	$ 868 M	USA
X4 Pharmaceuticals XFOR	46.1	$ 4.07	-5.57 %	$ 172 M	USA
Xencor XNCR	131	$ 11.4	-7.43 %	$ 846 M	USA
XOMA Corporation XOMA	23.6	$ 29.93	-1.97 %	$ 362 M	USA
22nd Century Group XXII	54.9	$ 2.41	-18.03 %	$ 444 K	USA
BioDelivery Sciences International BDSI	115	-	-4.8 %	$ 255 M	USA
Cara Therapeutics CARA	52.4	-	-3.03 %	$ 260 M	USA
ChemoCentryx CCXI	3.1	-	-	$ 3.74 B	USA